Molecular Engineering of Functional SiRNA Agents

Neelu Batra(University of California, Davis), Ai‐Ming Yu(University at Buffalo, State University of New York)

ACS Synthetic Biology

May 11, 2024

10.1021/acssynbio.4c00181

Cited by 7

Related Papers

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy

|Journal of Pharmacology and Experimental Therapeutics|2018|68

Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells

|Drug Metabolism and Disposition|2017|62

Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity

|Drug Metabolism and Disposition|2015|60

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest

|Scientific Reports|2016|43

Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models

|Oncotarget|2017|29